Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Tolstoshev is active.

Publication


Featured researches published by Paul Tolstoshev.


Lung | 1978

Cells, collagen and idiopathic pulmonary fibrosis

Ronald G. Crystal; Jack D. Fulmer; Bruce J. Baum; John Bernardo; Kathryn H. Bradley; Sally D. Bruel; Norton A. Elson; Gerald A. Fells; Victor J. Ferrans; James E. Gadek; Gary W. Hunninghake; Oichi Kawanami; Jeffrey A. Kelman; Bruce R. Line; John A. McDonald; Bryon D. McLees; William C. Roberts; David M. Rosenberg; Paul Tolstoshev; Edwyna Von Gal; Steven E. Weinberger

Idiopathic pulmonary fibrosis (IPF) is a usually fatal disorder of lung with clearly defined clinical, roentgenographic, physiologic, morphologic, scintigraphic and bronchoalveolar lavage features. Current concepts of the pathogenesis of this disorder suggest a central role for a chronic alveolitis in causing changes in parenchymal cell populations and derangements in interstitial collagen. Of the many inflammatory and immune effector cells comprising the alveolitis of IPF, it is likely that the neutrophil is the most important mediator of parenchymal damage. To follow the status of lung neutrophils in patients with this disease, two methods have been utilized. Both gallium-67 scanning and bronchoalveolar lavage quantitate the extent of the alveolitis and can be used to stage and follow these patients. The treatment of IPF remains controversial, but it is likely that corticosteroids reduce the alveolitis and prolong the lifespan of these patients.


Biochemical and Biophysical Research Communications | 1979

Procollagen α2 mRNA is significantly different from procollagen α1(I) mRNA in size or secondary structure

Paul Tolstoshev; Roberta Haber; Ronald G. Crystal

Abstract The fractionation of fetal calf tendon messenger RNA in 85 percent formamide sucrose gradients shows a separation of the mRNAs coding for pro α1(I) and pro α2 chains of type I collagen. This difference in sedimentation in denaturing gradients suggests that pro α2 mRNA is approxmately 1000 bases shorter than pro α1(I) mRNA. However, such a size difference is significantly greater than would be predicted from consideration of the size of the polypeptide chains coded for by these mRNAs, and thus, residual secondary structure in the mRNAs may contribute to these apparent size differences.


web science | 1976

The divergence between human and baboon globin genes.

Raymond Dalgleish; Robert Williamson; Paul Tolstoshev

Complementary DNA (cDNA) was prepared with viral RNA-directed DNA polymerase from purified baboon globin messenger RNA (mRNA). Homologous and heterologous hybrids between human and baboon mRNAs and cDNAs were compared for extent of hybridisation and thermal stability. Higher mRNA inputs to the hybridizations were required to reach saturation in the heterologous cases. The melting temperature of the heterologous hybrid was 5 degrees C lower than the homologous hybrid. Between these two primates, divergence has occurred in the globin gene to a smaller extent than that possible from third position changes in the coding sequences of the divergence of total DNA. Globin cDNA prepared from baboon will not in general be useful as a probe for human globin mRNA or human globin gene sequences.


Nucleic Acids Research | 1983

Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX

Michael Jaye; Fabienne Schamber; Alain Balland; Vipin Kohli; Annie Findeli; Paul Tolstoshev; Jean-Pierre Lecocq


web science | 1986

Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth

M. Miskulin; Raymond Dalgleish; Barbara Kluve-Beckerman; Stephen I. Rennard; Paul Tolstoshev; Mark L. Brantly; Ronald G. Crystal


Human Gene Therapy | 1994

Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA.

Nanette Mittereder; Soonpin Yei; Cindy J. Bachurski; John Cuppoletti; Jeffrey A. Whitsett; Paul Tolstoshev; Bruce C. Trapnell


Nature | 1985

Active γ-carboxylated human factor IX expressedusing recombinant DNA techniques

Werner Altenburger; René Elkaim; Karin Dott; Annick Dieterlé; Robert Drillien; Jean-Pierre Cazenave; Paul Tolstoshev; Jean-Pierre Lecocq


Journal of Biological Chemistry | 1981

Procollagen production and procollagen messenger RNA levels and activity in human lung fibroblasts during periods of rapid and stationary growth.

Paul Tolstoshev; Richard A. Berg; S I Rennard; K H Bradley; Bruce C. Trapnell; Ronald G. Crystal


Archive | 1985

Expression vectors for hirudin, transformed cells and process for the preparation of hirudin

Paul Tolstoshev; Richard Harvey; Michael Courtney; Jean-Pierre Lecocq


Journal of Biological Chemistry | 1981

Procollagen messenger RNA levels and activity and collagen synthesis during the fetal development of sheep lung, tendon, and skin.

Paul Tolstoshev; R Haber; Bruce C. Trapnell; Ronald G. Crystal

Collaboration


Dive into the Paul Tolstoshev's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruce C. Trapnell

Cincinnati Children's Hospital Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arthur W. Nienhuis

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

McDonagh Kt

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge